Page 8 - Minzhang Chen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Minzhang chen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Minzhang Chen Today - Breaking & Trending Today

Fierce Pharma Asia—WuXi-BMS plant deal; Clover-GSK COVID-19 vax pact ends; Illumina-Sequoia genomics incubator

Feb 5, 2021 9:40am
WuXi STA and Bristol Myers Squibb, Clover Biopharma and GlaxoSmithKline, and Illumina and Sequoia Capital made our news this week. (Google)
Bristol Myers Squibb is selling a Swiss tablet and capsule plant to WuXi STA. China s Clover Biopharma will use Dynavax s adjuvant, rather than GlaxoSmithKline s, as it moves its COVID-19 vaccine into a phase 3 trial. Illumina and Sequoia Capital China established a genomics startup incubator in Shanghai. And more.
WuXi STA is buying a Bristol Myers Squibb tablet and capsule production plant in Couvet, Switzerland. Financial terms were not disclosed. The Chinese CDMO plans to use the facility as a commercial manufacturing and supply center and a lever for breaking into the European market, CEO Minzhang Chen said. The company already runs facilities in the U.S. and China. ....

Switzerland General , United Kingdom , San Francisco , United States , Denny Lanfear , Junshi Biosciences , Coherus Biosciences , Minzhang Chen , Eli Lilly , Clover Biopharma , Lilly Alimta , Merck Co , Bristol Myers Squibb , Sequoia Capital China , சுவிட்சர்லாந்து ஜநரல் , ஒன்றுபட்டது கிஂக்டம் , சான் பிரான்சிஸ்கோ , ஒன்றுபட்டது மாநிலங்களில் , எலி லில்லி , மெர்க் இணை , பிரிஸ்டல் மைஸ் ஸ்க்விப்ப் , சீக்வோயா மூலதனம் சீனா ,

WuXi STA to purchase Bristol Myers Squibb manufacturing facility in Switzerland

WuXi STA to purchase Bristol Myers Squibb manufacturing facility in Switzerland
WuXi STA to purchase Bristol Myers Squibb manufacturing facility in Switzerland
03 February 2021 | News
The companies anticipate completing the transaction by Q2 2021, subject to regulatory approvals and the satisfaction of other closing conditions
Source: Business Wire
Bristol Myers Squibb and WuXi STA – a subsidiary of WuXi AppTec – have announced that WuXi STA has agreed to purchase Bristol Myers Squibb’s manufacturing facility in Couvet, Switzerland. The Couvet site will be the first facility in Europe for WuXi STA, a leading contract development and manufacturing organisation. The acquisition will enhance WuXi STA’s existing capabilities while growing capacity to support its partners’ life-saving work. ....

Switzerland General , Lou Schmukler , Minzhang Chen , Bristol Myers Squibb , Global Product Development , Wuxi Apptec , Executive Vice President , Bristol Myers , சுவிட்சர்லாந்து ஜநரல் , பிரிஸ்டல் மைஸ் ஸ்க்விப்ப் , உலகளாவிய ப்ராடக்ட் வளர்ச்சி , நிர்வாகி துணை ப்ரெஸிடெஂட் , பிரிஸ்டல் மைஸ் ,

Wuxi STA to Acquire Bristol Myers Squibb's Manufacturing Unit in Switzerland

Wuxi STA to Acquire Bristol Myers Squibb’s Manufacturing Unit in Switzerland
Switzerland: Pharma Deal Wuxi STA to Acquire Bristol Myers Squibb’s Manufacturing Unit in Switzerland
04.02.2021Editor:
Ahlam Rais
Located in Couvet, Switzerland, Bristol Myers Squibb’s manufacturing facility will be Wuxi STA’s first plant in Europe. On completion of the deal, Wuxi STA is expected to acquire the Couvet site’s operations and assets.
Related Companies
(Source: Bristol Myers Squibb)
USA – Bristol Myers Squibb and Wuxi STA – a subsidiary of Wuxi Apptec – have recently announced that Wuxi STA has agreed to purchase Bristol Myers Squibb’s manufacturing facility in Couvet, Switzerland. The Couvet site will be the first facility in Europe for Wuxi STA, a leading Contract Development and Manufacturing Organization. The acquisition will enhance Wuxi ....

Switzerland General , United States , Lou Schmukler , Minzhang Chen , Bristol Myers Squibb , Contract Development , Global Product Development , Manufacturing Organization , Pharma Deal , Acquire Bristol Myers Squibb , Manufacturing Unit , Myers Squibb , Wuxi Apptec , Pharmaceutical Equipment Market , Action As China , Executive Vice President , Bristol Myers , சுவிட்சர்லாந்து ஜநரல் , ஒன்றுபட்டது மாநிலங்களில் , பிரிஸ்டல் மைஸ் ஸ்க்விப்ப் , ஒப்பந்த வளர்ச்சி , உலகளாவிய ப்ராடக்ட் வளர்ச்சி , உற்பத்தி ஆர்கநைஸேஶந் , பார்மா ஒப்பந்தம் , பெறுங்கள் பிரிஸ்டல் மைஸ் ஸ்க்விப்ப் , உற்பத்தி அலகு ,

WuXi STA to buy manufacturing facility from Bristol Myers Squibb

WuXi STA to buy manufacturing facility from Bristol Myers Squibb
pharmaceutical-business-review.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-business-review.com Daily Mail and Mail on Sunday newspapers.

Switzerland General , Lou Schmukler , Minzhang Chen , Bristol Myers Squibb , Global Product Development , Myers Squibb , சுவிட்சர்லாந்து ஜநரல் , பிரிஸ்டல் மைஸ் ஸ்க்விப்ப் , உலகளாவிய ப்ராடக்ட் வளர்ச்சி , மைஸ் ஸ்க்விப்ப் ,

Bristol Myers Squibb to Sell Tablets and Capsules Plant

Biopharmaceutical firm Bristol Myers Squibb entered into an agreement to sell its Couvet, Switzerland manufacturing facility for tablets and capsules to Shanghai-based CDMO WuXi STA, a subsidiary of WuXi AppTec, the companies announced in a joint release Tuesday.
“The Couvet site is a world-class facility designed for quality, safety, and efficiency, and we believe WuXi STA will be able to leverage the capacity and capabilities for its own operations as it continues to play a vital role for patients around the world,” Lou Schmukler, executive vice president and president, Global Product Development and Supply for Bristol Myers Squibb, said in a statement. “This is an important step in the ongoing evolution of our manufacturing network to support our product portfolio.” ....

Switzerland General , Lou Schmukler , Minzhang Chen , Bristol Myers Squibb , Global Product Development , Wuxi Apptec , Myers Squibb , சுவிட்சர்லாந்து ஜநரல் , பிரிஸ்டல் மைஸ் ஸ்க்விப்ப் , உலகளாவிய ப்ராடக்ட் வளர்ச்சி , மைஸ் ஸ்க்விப்ப் ,